KYMR Stock Analysis: Buy, Sell, or Hold?
KYMR - Kymera Therapeutics, Inc. Common Stock
$100.60
2.35 (2.39%)
▲
5d:
+15.05%
30d:
+27.52%
90d:
+35.18%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When KYMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: KYMR is 13.6% above its trading range ($88.55). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: KYMR is 13.6% above its trading range ($88.55). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: KYMR is currently trading at $100.60, which is considered extended relative to its 30-day fair value range of $74.97 to $88.55.
Technical Outlook: Technically, KYMR is showing sideways momentum. Immediate support is located at $73.05, while resistance sits at $105.00.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $119.19 (+21.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KYMR is showing sideways momentum. Immediate support is located at $73.05, while resistance sits at $105.00.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $119.19 (+21.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$74.97 -
$88.55
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
KYMR is technically overbought (RSI 73). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+13.6% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 21.3% below Wall St target ($119.19)
Trading Range Analysis
30-Day Trading Range
$74.97 -
$88.55
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$73.05
Resistance Level
$105.00
Current Trend
Sideways
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-22.61
Wall Street Target
$119.19
(+21.3%)
Revenue Growth (YoY)
55.5%
Share & Embed Analysis
Last updated: June 24, 2026 10:53 AM ET
Data refreshes hourly during market hours. Next update: 11:53 AM
Data refreshes hourly during market hours. Next update: 11:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYMR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Bruce Booth
SELL
5900 shares
2026-04-22
Jeremy G Chadwick
SELL
300 shares
2026-04-22
Bruce Booth
SELL
100 shares
2026-04-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 67 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 65 BUY |
|
MNMD
Mind Medicine Inc |
STRONG BUY
11 analysts |
$29 | 62 BUY |
|
ALLO
Allogene Therapeutics Inc |
STRONG BUY
14 analysts |
$8 | 60 HOLD |
Advanced KYMR Option Strategies
Professional options setups generated by AI based on today's KYMR price and gamma walls.
